Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$4.02 - $5.39 $691 - $927
-172 Reduced 0.85%
19,980 $84,000
Q4 2023

Feb 13, 2024

BUY
$4.0 - $5.49 $620 - $850
155 Added 0.78%
20,152 $107,000
Q3 2023

Nov 13, 2023

BUY
$4.0 - $5.82 $4,672 - $6,797
1,168 Added 6.2%
19,997 $85,000
Q2 2023

Aug 04, 2023

BUY
$4.19 - $6.16 $78,893 - $115,986
18,829 New
18,829 $103,000
Q2 2022

Aug 12, 2022

SELL
$3.28 - $6.42 $63,976 - $125,222
-19,505 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$5.16 - $7.14 $7,084 - $9,803
-1,373 Reduced 6.58%
19,505 $121,000
Q4 2021

Feb 11, 2022

SELL
$6.37 - $8.18 $3,974 - $5,104
-624 Reduced 2.9%
20,878 $147,000
Q3 2021

Nov 12, 2021

SELL
$6.98 - $8.47 $530 - $643
-76 Reduced 0.35%
21,502 $150,000
Q2 2021

Aug 13, 2021

SELL
$5.44 - $8.4 $3,987 - $6,157
-733 Reduced 3.29%
21,578 $180,000
Q1 2021

May 07, 2021

BUY
$3.91 - $6.99 $226 - $405
58 Added 0.26%
22,311 $122,000
Q4 2020

Feb 12, 2021

SELL
$3.0 - $4.5 $1,914 - $2,871
-638 Reduced 2.79%
22,253 $95,000
Q3 2020

Nov 04, 2020

SELL
$2.75 - $4.2 $500 - $764
-182 Reduced 0.79%
22,891 $69,000
Q2 2020

Aug 12, 2020

BUY
$2.12 - $3.14 $48,914 - $72,449
23,073 New
23,073 $72,000
Q2 2019

Aug 13, 2019

SELL
$1.93 - $4.59 $44,818 - $106,588
-23,222 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$2.77 - $4.38 $2,083 - $3,293
-752 Reduced 3.14%
23,222 $100,000
Q4 2018

Feb 13, 2019

BUY
$3.03 - $5.0 $848 - $1,400
280 Added 1.18%
23,974 $76,000
Q3 2018

Nov 09, 2018

BUY
$5.0 - $6.65 $4,035 - $5,366
807 Added 3.53%
23,694 $124,000
Q2 2018

Aug 08, 2018

BUY
$4.2 - $5.95 $96,125 - $136,177
22,887 New
22,887 $122,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.